Chemoprophylaxis
with oseltamivir either for short duration (10 days) or of long
duration (42 days) protect the individual till such time he is on
Chemoprophylaxis. In a community where there is rampant spread of
pandemic Influenza A H1N1, the risk of getting the infection exists the
moment a person is taken off Chemoprophylaxis. As prophylaxis cannot be
continued in perpetuity, the following recommended:
- If the States qualify the criteria for community spread, then
Chemoprophylaxis would only be provided to family contacts that are at
high risk and especially those with comorbid condition.
- The prophylaxis to the high risk family contact would be provided
irrespective of laboratory testing i.e. any high risk contact of
patients in category A, B or C would be provided Chemoprophylaxis.
- The doctors screening the patients and categorizing them as A,B,C
would invariably take the history of high risk contacts among the family
members of these suspect cases and persuade them to attend screening
centres.
- The prophylaxis to the high risk family contact would be provided
irrespective of laboratory testing i.e. any high risk contact of
patients in category A, B or C would be provided Chemoprophylaxis.
- Irrespective of whether there is a community spread or not medical personnel attending to influenza A H1N1 cases in dedicated treatment facilities would be put on Chemoprophylaxis to a maximum of 42 days.
Comments
Post a Comment